PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | -50.0% | 352 | -47.2% | 0.00% | – |
| Q1 2020 | $2,000 | -50.0% | 667 | -51.8% | 0.00% | – |
| Q4 2019 | $4,000 | -55.6% | 1,385 | -67.4% | 0.00% | -100.0% |
| Q3 2019 | $9,000 | -10.0% | 4,246 | +35.9% | 0.00% | 0.0% |
| Q2 2019 | $10,000 | -16.7% | 3,125 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $12,000 | +50.0% | 3,125 | +6.8% | 0.00% | 0.0% |
| Q4 2018 | $8,000 | 0.0% | 2,925 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $8,000 | +166.7% | 2,925 | +111.2% | 0.00% | – |
| Q2 2018 | $3,000 | – | 1,385 | +5921.7% | 0.00% | – |
| Q4 2014 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 23 | -94.9% | 0.00% | -100.0% |
| Q1 2014 | $4,000 | – | 448 | +1847.8% | 0.00% | – |
| Q4 2013 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2013 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |